SBC Medical Expands Japan Footprint with Waqoo Acquisition
SBC Medical Group Holdings has solidified its position in Japan's regenerative medicine sector through the successful completion of its tender offer for Waqoo, Inc. The $4.18-per-share healthcare technology firm will acquire over 575,000 shares at ¥1,900 each, totaling approximately ¥1.09 billion. Settlement begins December 19, 2025, granting SBC majority voting rights exceeding 50%.
The strategic MOVE enhances SBC's R&D capabilities in regenerative medicine while expanding its Asian market presence. Investors view the transaction as a calculated step in the company's long-term global expansion strategy, evidenced by SBC's 1.46% stock price increase following the announcement.